| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4483b7dcfa169d7ea8a61300461c0b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92d0e9a685fded1fcacbe76b4d869408 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 |
| filingDate |
2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922244a4a1fec98f5d80634b65876350
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6afc16b25ef43de2308afaf8f020825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b8fdd030c792912c05525362acb5917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_509d3fa8e510814f44bfec1c81f87e70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f40253a549faa439e1adf7c41012dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa498cb9e202dfaa7a1e01409855804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca2ecc520120bc0e927e0783ef45d03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd9c691d349e69cd45862d985cd98ec9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d218beedb16526b60e1acb52de6ea6 |
| publicationDate |
2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2011265368-B2 |
| titleOfInvention |
Immunogenic composition |
| abstract |
Abstract: The present application relates to immunogenic compositions and vaccines useful for the prevention or treatment of staphylococcal disease. Such immunogenic compositions include combinations of antigens which allow a particularly effective immune response to be generated when included in combination with other staphylococcal antigens. Examples of such combinations include HarA in combination with further staphylococcal antigens. |
| priorityDate |
2004-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |